Ads
related to: triple negative breast cancer website free search- Clinical Trial Results
Learn About Clinical Trial Results
In Patients Like Yours.
- Request A Rep
Request a Representative & Discover
More About Treatment Option.
- Prescription Info
Find Dosing Guides & Safety
Information Here.
- Ordering Information
Find Out More About Ordering
A Treatment For Your Patients.
- Clinical Trial Design
Learn More About Clinical Trial
And Study Results Today.
- Nurses Station
Explore Resources Made For Nurses
To Learn About A mTNBC Treatment.
- Clinical Trial Results
Search results
Results From The WOW.Com Content Network
Triple-negative is sometimes used as a surrogate term for basal-like. [2] Triple-negative breast cancer comprises 15–20% of all breast cancer cases [3] and affects more young women or women with a mutation in the BRCA1 gene than other breast cancers. [4] Triple-negative breast cancers comprise a very heterogeneous group of cancers.
The Triple Negative Breast Cancer Foundation ("TNBC Foundation") is a nonprofit organization dedicated to raising awareness of triple negative breast cancer.The foundation supports scientists and researchers in their efforts to determine the definitive causes of triple negative breast cancer so that effective detection, diagnosis, prevention, and treatment can be pursued and achieved.
Breast cancer is the most common cancer in women worldwide, and can, rarely, also occur in men. There are many different types of breast cancer, of which triple-negative breast cancer is one of ...
In 2005, LBBC secured funding for the Silent Voices: Advanced (Metastatic) Breast Cancer Needs Assessment Survey (2006), an important first step in identifying concerns specific to women with Stage IV breast cancer. [23] [9] [7] In 2013–2014, LBBC carried out the first needs assessment of women diagnosed with triple-negative breast cancer ...
Researchers from Florida A&M University found a natural compound found in cardamom is capable of destroying triple-negative breast cancer cells. The compound cardamonin is also found in other plants.
MDA-MB-231 (M D Anderson - Metastatic Breast - 231) is a human breast cancer cell line isolated at MD Anderson Cancer Center in 1973 that is used in therapeutic research, especially in the context of triple negative breast cancer. [1] [2]
Ad
related to: triple negative breast cancer website free search